Fig. 4

Effects of ATO and DEX on the expression of M2 markers. a Representative images of western blots showing CD206, SR-BI and Arg-1 expression. b Quantification of CD206, one-way ANOVA, P = 0.001; compared with the LPS group, Bonferroni test, ^***P = 0.003, ^*P < 0.05. LPS+0.01D+0.1A group vs. LPS+0.01D group, unpaired Student’s t test, P = 0.009. c Quantification of SR-BI, one-way ANOVA, P < 0.001; compared with the LPS group, Bonferroni test, ^***P < 0.005, ^*P = 0.044. LPS+0.01D+0.1A group vs. LPS+0.1A group, unpaired Student’s t test, P = 0.021. d Quantification of Arg-1, one-way ANOVA, P = 0.006; compared with the LPS group, Bonferroni test, ^**P = 0.007, ^*P < 0.05. e The mRNA expression of IL-10, one-way ANOVA, P < 0.001; compared with the LPS group, the Bonferroni test, ^***P = 0.001, ^*P = 0.031. LPS+0.01D+0.1A group vs. LPS+0.1A group, unpaired Student’s t test, P = 0.012, LPS+0.01D+0.1A group vs. LPS+0.01D group, unpaired Student’s t test, P = 0.026. Note: A, atorvastatin; Arg-1, Arginase-1; D, dexamethasone; SR-B1, Scavenger receptor class B type I